These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9506875

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee.
    Goei Thè HS, Lund B, Distel MR, Bluhmki E.
    Osteoarthritis Cartilage; 1997 Jul; 5(4):283-8. PubMed ID: 9404473
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
    Altman R, Hochberg M, Gibofsky A, Jaros M, Young C.
    Curr Med Res Opin; 2015 Dec; 31(12):2331-43. PubMed ID: 26503347
    [Abstract] [Full Text] [Related]

  • 6. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
    Lindén B, Distel M, Bluhmki E.
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():35-8. PubMed ID: 8630634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Review of clinical trials and benefit/risk ratio of meloxicam.
    Barner A.
    Scand J Rheumatol Suppl; 1996 Apr; 102():29-37. PubMed ID: 8628979
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety of meloxicam: a global analysis of clinical trials.
    Distel M, Mueller C, Bluhmki E, Fries J.
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():68-77. PubMed ID: 8630641
    [Abstract] [Full Text] [Related]

  • 13. A randomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin-Beck disease of the knee.
    Tang X, Pei FX, Zhou ZK, Liu G, Shen B, Kang PD, Li J, Zhao XD, Li Q, Li Y.
    Clin Rheumatol; 2012 Jul; 31(7):1079-86. PubMed ID: 22476807
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.
    Wojtulewski JA, Schattenkirchner M, Barceló P, Le Loët X, Bevis PJ, Bluhmki E, Distel M.
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():22-8. PubMed ID: 8630632
    [Abstract] [Full Text] [Related]

  • 16. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.
    Dequeker J, Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, Bégaud B, Isomäki H, Littlejohn G, Mau J, Papazoglou S.
    Br J Rheumatol; 1998 Sep; 37(9):946-51. PubMed ID: 9783758
    [Abstract] [Full Text] [Related]

  • 17. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE, Kolba KS, Fleischmann R, Silverfield J, Greenwald M, Roth S, Hall DB, Roszko PJ, Meloxicam Rheumatoid Arthritis Investigators.
    J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
    Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, Joos R, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M, Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M, Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S, Pediatric Rheumatology International Trials Organization.
    Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.